Abstract:Streptococcus pneumoniae is a leading cause of morbidity and mortality in children and older adults. Yet knowledge on the development of pneumococcal protein-specific antibody responses throughout life is limited. To investigate this, we measured serum IgG levels to 55 pneumococcal proteins in 11-month old infants (n=73), 24-month old children (n=101), parents (n=99), adults without children 60 years (n=100). Our findings revealed low IgG levels in infancy, with distinct development patterns peaking in adults. A decrease in levels was observed for 27 antigens towards older age. Adults and older adults had increased IgG levels during pneumococcal carriage and at increased exposure risk to S. pneumoniae . Carriage was a stronger predictor than exposure or age for antibody responses. These findings highlight the dynamic nature of naturally acquired humoral immunity to pneumococcal proteins throughout life, offering insights for age-targeted interventions.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the development pattern of the immune response of Streptococcus pneumoniae protein - specific antibodies and its changes with age. Specifically, the research aims to: 1. **Gain in - depth understanding of the development pattern of Streptococcus pneumoniae protein - specific antibodies**: By measuring the serum IgG levels of 55 Streptococcus pneumoniae proteins in people of different age groups (from 11 - month - old infants to the elderly over 60 years old), the researchers hope to reveal the unique patterns of acquisition, maintenance and decline of these antibodies throughout the life cycle. 2. **Evaluate the impact of Streptococcus pneumoniae carriage and exposure risk on antibody levels**: The researchers also explored how the carriage status of Streptococcus pneumoniae and the frequency of contact with children under 6 years old affect the antibody levels of individuals of different age groups. In particular, they want to know whether these factors are more predictive of antibody levels than age itself. 3. **Provide insights into age - specific intervention measures**: Through detailed comparison of antibody levels in different age groups, the researchers hope to be able to provide a scientific basis for formulating age - specific vaccines or other intervention measures. ### Main findings - **Antibody levels are the lowest in infancy**: The study found that the IgG levels of 11 - month - old infants against most Streptococcus pneumoniae proteins are the lowest, and the antibody levels gradually increase with age. - **Four different antibody development patterns**: - **Gradually increasing type**: The antibody levels of most proteins (32/55) gradually increase from infancy to adulthood. - **Early elevation followed by maintenance type**: The antibody levels of 17 proteins reach the adult level at 24 months of age and are maintained thereafter. - **Delayed increasing type**: The antibody levels of 17 proteins are still low at 24 months of age but gradually increase after adulthood. - **Stable type**: The antibody levels of 6 proteins reach a stable level in early life and are maintained until old age. - **Antibody levels of some antigens decline in the elderly**: The antibody levels of 27 proteins decline significantly in the elderly, which may explain the increased susceptibility of the elderly to invasive Streptococcus pneumoniae disease (IPD). - **Streptococcus pneumoniae carriage is an important predictor of antibody levels**: The study found that the current Streptococcus pneumoniae carriage status is the most important clinical factor in predicting protein - specific antibody levels, exceeding age and exposure risk. ### Conclusion This study provides detailed insights into the development and changes of the immune response of Streptococcus pneumoniae protein - specific antibodies in different age groups, emphasizing the important role of Streptococcus pneumoniae carriage in maintaining antibody levels. These findings are helpful for the future design of age - specific vaccines and intervention measures.

Serological profiling of pneumococcal proteins reveals unique patterns of acquisition, maintenance and waning of antibodies throughout life

Quantity and Quality of Naturally Acquired Antibody Immunity to the Pneumococcal Proteome Throughout Life

Genomic and panproteomic analysis of the development of infant immune responses to antigenically-diverse pneumococci

Persistence of immunity in children aged 2 months and 7 months - 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine

Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages

Serum IgG Profiling of Toddlers Reveals a Subgroup with Elevated Seropositive Antibodies to Viruses Correlating with Increased Vaccine and Autoantigen Responses

Pneumococcal antibody response in children with recurrent respiratory tract infections: A descriptive study

Kinetics of IgM and IgA Antibody Response to 23-Valent Pneumococcal Polysaccharide Vaccination in Healthy Subjects

Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses

Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults

Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study

State of pneumococcal vaccine immunity

Investigation on the correlation factors of positive Streptococcus pneumoniae antibody and IgG antibody level of Streptococcus pneumoniae in the elderly over 60 years old in Shenzhen

The Divergent Effect of Different Infant Vaccination Schedules of the 13-Valent Pneumococcal Conjugate Vaccine on Serotype-Specific Immunological Memory

No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort

Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C

Non-linear relationships between children age and pneumococcal vaccine coverage: Important implications for vaccine prevention strategies

Impact of age on pneumococcal colonization of the nasopharynx and oral cavity: an ecological perspective

Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with β-thalassemia: assessing the need for booster

Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults

Nasopharyngeal colonization by Streptococcus pneumoniae and other common bacteria eight years following introduction of pneumococcal conjugate vaccine in rural South African children ≤5 years old.